Early Phase Clinical Development Strategies to Secure Funding
Kavon ClinReg accelerates early-phase biotech success by delivering regulatory and clinical trial strategies that validate outcomes, integrate commercial readiness, and unlock investor confidence.
About Kavon ClinReg
Kavon specializes in helping “start-up” biotech companies move their pre-clinical and early phase clinical programs forward by providing tailored regulatory and clinical advisory support. We focus on engaging with the right CROs, effectively managing the budget, successfully meeting the required timelines, and efficiently forecasting the number of subjects (healthy volunteers and/or patients).
Streamlining Clinical Trial
Pathways For Our Clients
What We Do Best
At Kavon ClinReg we offer a wide range of regulatory and clinical services including:
Specialized Consulting
& Outsourcing Expertise
Regulatory Strategy & Submission Support
Clinical Development Planning
Medical Writing
Recruitment & Operations Support
Compliance Consulting
“Kavon ClinReg has been instrumental to OS Therapies’ early growth, bringing regulatory and clinical expertise, global networks and the strategic insight to help raise capital and advance novel treatments. They are a trusted partner for any biotech pushing forward innovation in serious diseases.”
— PAUL ROMNESS, CHAIR, CEO & PRESIDENT OF OS THERAPIES
Let’s accelerate your trial efficiently and effectively.
Schedule your personalized consultation today.